With reference to the drug shortage in Kerala, consider the following statements: 1. The shortage primarily affects drugs used to treat infectious diseases. 2. The Kerala Medical Services Corporation Limited (KMSCL) owes over ₹2,200 crore to pharmaceutical firms. 3. The Health Minister has proposed allowing direct importers to participate in tenders. Which of the statements given above is/are correct?

Kerala hospitals face drug shortages as KMSCL owes pharma firms over ₹2,200 crore

GS2Polity · Governance · IR· Health policy & public health· Prelims + Mains· 2 October 2026

Public procurement and supply chain resilience in healthcare: a GS2 Social Justice and GS3 infrastructure case study.

Why in news

Kerala hospitals are facing shortages of non-communicable disease drugs due to a ₹2,200 crore debt owed by the Kerala Medical Services Corporation Limited (KMSCL) to pharmaceutical firms.

Background

KMSCL failed to release supplies in June and only released first-quarter supplies this year. Health Minister K. Muraleedharan has ordered procurement by December, proposing the removal of middlemen and allowing direct importers to participate in tenders.

Facts for Prelims

FactKMSCL owes over ₹2,200 crore to pharmaceutical firms.
FactShortages reported for non-communicable disease drugs including metformin, telmasartan, and atorvastatin.
PostK. Muraleedharan is the Health Minister of Kerala.

Prelims practice question

With reference to the drug shortage in Kerala, consider the following statements:

The shortage primarily affects drugs used to treat infectious diseases.
The Kerala Medical Services Corporation Limited (KMSCL) owes over ₹2,200 crore to pharmaceutical firms.
The Health Minister has proposed allowing direct importers to participate in tenders.

Which of the statements given above is/are correct?

(a)2 only
(b)1 and 3 only
(c)2 and 3 only
(d)1, 2 and 3

Show answer

Answer: (c) 2 and 3 only — Statements 2 and 3 are correct. Statement 1 is incorrect: The shortage affects non-communicable disease drugs.

For Mains

Q. Analyze the systemic issues in public procurement of essential medicines and suggest measures to ensure supply chain resilience in state-run healthcare systems.

Dimensions to cover in your answer

Procurement bottleneck: Debt accumulation and delayed payments to private pharma firms disrupting public health supply chains
Regulatory reform: Potential for direct importer participation to bypass middlemen and reduce costs
Logistical failure: Impact of delayed quarterly releases on the availability of chronic disease medications

Keywords: Public Procurement · Supply Chain Resilience · Non-communicable Diseases · Fiscal Deficit · Healthcare Infrastructure

Read the full news →Report a mistake in this note Source: The Hindu ↗Also: GS3 · Industry, investment & MSMEs

More Social Justice notes

Kerala to launch ‘Learn Happily’ campaign for academic pressure and substance abuse · 8 October 2026
Kerala allocates over ₹600 crore to clear Karunya health scheme pending claims · 8 October 2026
Union government caps trade margins at 30% to save ₹2,500 crore on cancer drugs · 8 October 2026
MoE trains 72 lakh teachers to use PRASHAST tool for 21 disability conditions · 8 October 2026
BBBP programme improved birth outcomes, adding about 15 girls per 1,000 births · 8 October 2026
Kerala government appoints commission to study state universities' financial status and sustainability · 8 October 2026

All Social Justice current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.